TipRanks
Novo Nordisk (DE:NOVA)
FRANKFURT:NOVA
Germany Market

Novo Nordisk (NOVA) Drug Pipeline

162 Followers
Drug Name
Condition
Stage
Status
Study Name
Trial Start Date
Article
Semaglutide
Obesity, Overweight
Phase III
Recruiting
Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
Aug 13, 2026
Semaglutide, Nnc0721-8060
Obesity, Overweight
Phase I
Recruiting
A First-in-human Research Study on How NNC0721-8060 Works in People Living With Overweight or Obesity
Aug 11, 2026
Nnc0487-0111, Led
Obesity, Overweight
Phase I
Recruiting
A Research Study to See How NNC0487-0111 Affects the Body's Energy Use After a Weight Loss in Adults Living With Obesity, Compared to a Low-calorie Diet or Placebo
Jul 30, 2026
Cagrilintide
Obesity, Overweight
Phase III
Recruiting
A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
Jul 30, 2026
Zenagamtide
Obesity, Overweight
Phase III
Not Yet Recruiting
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
Jul 17, 2026
Nnc6022-0004
Obesity, Elevated High-Sensitivity C-Reactive Protein (Hscrp)
Phase I
Recruiting
A Study to See How Safe a New Medicine (NNC6022-0004) is in Healthy People and People Living With Obesity
Jul 03, 2026
Semaglutide, Ubt251
Diabetes Mellitus, Type 2
Phase II
Recruiting
A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
Jun 19, 2026
Semaglutide, Zenagamtide
Obesity, Overweight
Phase III
Not Yet Recruiting
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
Jun 19, 2026
Zenagamtide
Obesity, Overweight
Phase III
Not Yet Recruiting
AMAZE 13: A Research Study Investigating How Well the Medicine Zenagamtide Helps People in Asia With Excess Body Weight Lose Weight
Jun 18, 2026
Semaglutide, Nnc0662-0419
Obesity
Phase II
Recruiting
A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity
Jun 05, 2026

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
    What is a clinical trial?
    A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
      What drugs does Novo Nordisk (NOVA) have in its pipeline
      NOVA is currently developing the following drugs: Semaglutide, Semaglutide, Nnc0721-8060, Nnc0487-0111, Led. These drug candidates are in various stages of clinical development as the company works toward FDA approval.